Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography imaging in pyogenic and tuberculous spondylitis: Preliminary study

Journal of Computer Assisted Tomography

Volumn 33, Issue 4, 2009, Pages 587-592

  Lee, In Sook ^a,b   Lee, Jung Sub ^a,b   Kim, Seong Jang ^a,b   Jun, Sungmin ^a,b   Suh, Keun Tak ^a,b  

^a Pusan National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Dual phase imaging; MRI; PET CT; Spondylitis; Standard uptake value

Indexed keywords

COMPUTERIZED TOMOGRAPHY; FLUORINE; POSITRON EMISSION TOMOGRAPHY; POSITRONS;

C-REACTIVE PROTEINS; DUAL PHASE; DUAL PHASIS; DUAL-PHASE IMAGING; FLUORINE-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHIES; PHASE IMAGING; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; SPONDYLITI; STANDARD UPTAKE VALUES; TOMOGRAPHY IMAGING;

MAGNETIC RESONANCE IMAGING;

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG UPTAKE; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSOAS MUSCLE; PYOGENIC SPONDYLITIS; SENSITIVITY AND SPECIFICITY; SPONDYLITIS; THORACIC SPINE; TUBERCULOUS SPONDYLITIS;

EID: 68949111976     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e318187fef8     Document Type: Article

References (35)

1. Gemmel F, Dumarey N, Palestro CJ. Radionuclide imaging of spinal infections. Eur J Nucl Med Mol Imaging. 2006;33:1226Y1237.
2. Tali ET. Spinal infections. Eur J Radiol. 2004;50:120Y133.
3. Sharif HS, Morgan JL, al Shahed MS, et al. Role of CTand MR imaging in the management of tuberculous spondylitis. Radiol Clin North Am. 1995;33:787Y804.
4. Arizono T, Oga M, Shiota E, et al. Differentiation of vertebral osteomyelitis and tuberculous spondylitis by magnetic resonance imaging. Int Orthop. 1995;19:319Y322.
5. Gratz S, Dorner J, Fischer U, et al. 18F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med Mol Imaging. 2002;29:516Y524.
6. Jung NY, Jee WH, Ha KY, et al. Discrimination of tuberculous spondylitis from pyogenic spondylitis on MRI. AJR Am J Roentgenol. 2004;182:1405Y1410.
7. Stumpe KD, Zanetti M, Weishaupt D, et al. FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging. AJR Am J Roentgenol. 2002;179:1151Y1157.
8. Schmitz A, Kalicke T, Willkomm P, et al. Use of fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in assessing the process of tuberculous spondylitis. J Spinal Disord. 2000;13:541Y544.
9. Vanninen E, Laitinen T, Partanen K, et al. Late correlative imaging findings of previous acute infective spondylitis. Clin Nucl Med. 2000;25:779Y784.
10. Cohade C, Wahl RL. Applications of positron emission tomography/ computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements. Semin Nucl Med. 2003;33:228Y237.
11. Townsend DW, Carney JP, Yap JT, et al. PET/CT today and tomorrow. J Nucl Med. 2004;45(suppl 1):4SY14S.
12. Dumarey N, Egrise D, Blocklet D, et al. Imaging infection with 18F-FDGYlabeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med. 2006;47:625Y632.
13. Desai SS. Early diagnosis of spinal tuberculosis by MRI. J Bone Joint Surg Br. 1994;76:863Y869.
14. Akman S, Sirvanci M, Talu U, et al. Magnetic resonance imaging of tuberculous spondylitis. Orthopedics. 2003;26:69Y73.
15. Almeida A. Tuberculosis of the spine and spinal cord. Eur J Radiol. 2005;55:193Y201.
16. Moorthy S, Prabhu NK. Spectrum of MR imaging findings in spinal tuberculosis. AJR Am J Roentgenol. 2002;179:979Y983.
17. Shanley DJ. Tuberculosis of the spine: imaging features. AJR Am J Roentgenol. 1995;164:659Y664.
18. Dagirmanjian A, Schils J, McHenry MC. MR imaging of spinal infections. Magn Reson Imaging Clin North Am. 1999;7:525Y538.
19. Stabler A, Reiser MF. Imaging of spinal infection. Radiol Clin North Am. 2001;39:115Y135.
20. Adatepe MH, Powell OM, Isaacs GH, et al. Hematogenous pyogenic vertebral osteomyelitis: diagnostic value of radionuclide bone imaging. J Nucl Med. 1986;27:1680Y1685.
21. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med. 1997;336:999Y1007.
22. Palestro CJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med. 1997;27:334Y345.
23. Gratz S, Dorner J, Oestmann JW, et al. 67Ga-citrate and 99Tcm-MDP for estimating the severity of vertebral osteomyelitis. Nucl Med Commun. 2000;21:111Y120.
24. Ichiya Y, Kuwabara Y, Sasaki M, et al. FDG-PET in infectious lesions: the detection and assessment of lesion activity. Ann Nucl Med. 1996;10:185Y191.
25. Guhlmann A, Brecht-Krauss D, Suger G, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology. 1998;206:749Y754.
26. Sugawara Y, Braun DK, Kison PV, et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med. 1998;25:1238Y1243.
27. Kalicke T, Schmitz A, Risse JH, et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med. 2000;27:524Y528.
28. Stumpe KD, Dazzi H, Schaffner A, et al. Infection imaging using whole-body FDG-PET. Eur J Nucl Med. 2000;27:822Y832.
29. Zhuang H, Duarte PS, Pourdehand M, et al. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med. 2000;25:281Y284.
30. Townsend DW. A combined PET/CT scanner: the choices. J Nucl Med. 2001;42:533Y534.
31. Katzel JA, Heiba SI. PET/CT F-18 FDG scan accurately identifies osteoporotic fractures in a patient with known metastatic colorectal cancer. Clin Nucl Med. 2005;30:651Y654.
32. Boellaard R, Krak NC, Hoekstra OS, et al. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med. 2004;45:1519Y1527.
33. Hustinx R, Smith RJ, Benard F, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med. 1999;26:1345Y1348.
34. Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412Y1417.
35. Alavi A, Lakhani P, Mavi A, et al. PET: a revolution in medical imaging. Radiol Clin North Am. 2004;42:983Y1001, vii.